Post date October 17, 2022 Experience European Biotech Acquisition $200 million combination with Oculis We are advising European Biotech Acquisition Corp. on its deSPAC transaction
Post date September 1, 2022 Experience Novo Nordisk $1.1 billion acquisition of Forma Therapeutics We are advising Novo Nordisk on the transaction
Post date August 19, 2022 Experience Esco Aster spinoff transactions We are advising Esco Lifesciences on the spinoff
Post date August 19, 2022 Experience Freeman Spogli investment in EverVet We advised Tailwind Capital and EverVet on the transaction
Post date August 11, 2022 Experience InSilico Medicine $35 million Series D2 financing We are advising InSilico Medicine on the financing
Post date August 4, 2022 Experience Gilead Sciences $405 million acquisition of MiroBio We are advising Gilead Sciences on the transaction
Post date August 3, 2022 Experience Taibang Biologic Group $300 million equity raising We are advising Taibang Biologic Group in connection with its equity raising by a group of investors
Post date July 5, 2022 Experience Precigen sale of Trans Ova Genetics to URUS We are advising Precigen on the transaction
Post date July 1, 2022 Experience Acutus Medical sale of its left-heart access portfolio products and refinancing We advised Acutus Medical on the transactions
Post date June 21, 2022 Experience TPG Capital $1.1 billion take-private acquisition of Convey Health Solutions We are advising TPG Capital on the transaction